Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
GIP receptor activation Glucose-dependent insulinotropic polypeptide (GIP) is the second receptor target, similar to tirzepatide (Mounjaro, Zepbound): Effects: Enhances insulin release from the pancreas Works synergistically with GLP-1 for appetite control May influence fat storage and energy balance Improves glucose regulation Tirzepatide's success as a dual GLP-1/GIP agonist demonstrated that adding GIP to GLP-1 enhances weight loss beyond GLP-1 alone
Anthony Collova , Founder, IIFYM.com 15+ years coaching macro tracking & fat loss ~14 min Medical disclaimer: This article is for educational purposes only and isn't medical advice
Diabetes 53: 13261335
With a large diabetic and pre-diabetic population, GLP-1 therapies are gaining acceptance as dual-purpose treatments
US$ 23.52
US$ 26.69
US$ 24.39
.png&w=3840&q=75&dpl=dpl_91bb9r2rrQMVt6YcHHD1NQ3Gj1bm)
